Humaneva has filed a notice of an exempt offering of securities to raise $50,000,016.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Humaneva is raising up to $50,000,016.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Tomasz Dabrowski played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Humaneva
Humaneva stands at the intersection of Patient care and scientific innovation, offering reliable clinical research data that empowers the medical community. Humaneva Group emerged from our unwavering commitment to integrating clinical research with technological innovation and data-driven approaches. The Group consists of three interrelated companies, each excelling in its specialized domain within the field of clinical research. Individually outstanding, together they form a perfectly integrated alliance, creating a seamless data stream between Patients, Investigators, Research Centres, and data standards. OUR SUPERIOR CLIENT VALUE: direct access to Patients & reliable data on time. Our unique value proposition is based on three operational segments: 1. Our SMO (Pratia) organizations operations and expertise favor our ability to find the right patient at the right time and place; 2. Our in-house, state-of-the-art TECH (Hyggio) permeates and harmonizes operations at both the CRO and SMO levels, enabling scalable, comprehensive, cost-effective, fast and high-quality data analysis; 3. Managing clinical projects within the CRO (Kapadi) provides natural vertical integration synergies and superior savings of time and money for the sponsor. By prioritizing patient care, leveraging technology, and championing data excellence in oncology and other therapeutic areas, Humaneva Group is forging a path to groundbreaking discoveries and the betterment of Patient health worldwide. Join Humaneva Group in redefining the future of clinical research, where every Patients story contributes to a larger narrative of hope and healing.
To learn more about Humaneva, visit http://humaneva.com/
Humaneva Linkedin Page: https://www.linkedin.com/company/humaneva/
Contact:
Tomasz Dabrowski, Chief Executive Officer
813-498-1091
https://www.linkedin.com/in/tomek-dabrowski-62373630/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.